Brief: India's Neuland Labs Gets U.S. FDA Establishment Inspection Report For Hyderabad Facility
Aug 30 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* SAYS RECEIVED ESTABLISHMENT INSPECTION REPORT FROM U.S.
FDA FOR
ITS HYDERABAD FACILITY; INSPECTION NOW CLOSED
Further company coverage: NEUL.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees